We are live on ! Find out more
AAP

Arax Advisory Partners Portfolio holdings

AUM $3.54B
1-Year Est. Return 19.14%
This Fund
S&P 500
This Quarter Est. Return
+8.62%
1 Year Est. Return
+19.14%
3 Year Est. Return
+47.9%
5 Year Est. Return
+48.74%
10 Year Est. Return
AUM
$6.97B
AUM Growth
+$4.79B
Cap. Flow
+$6.91B
Cap. Flow %
99.25%
Top 10 Hldgs %
36.51%
Holding
4,400
New
1,371
Increased
1,984
Reduced
143
Closed
794

Sector Composition

Rank Sector Weight
1 Technology 13.48%
2 Financials 8.05%
3 Industrials 7.03%
4 Consumer Discretionary 6.62%
5 Healthcare 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UPLD icon
3076
Upland Software
UPLD
$12.8M
$2.37K ﹤0.01%
+100
New +$2.27K
III icon
3077
Information Services Group
III
$233M
$2.35K ﹤0.01%
+408
New +$2.03K
MFIN icon
3078
Medallion Financial
MFIN
$250M
$2.34K ﹤0.01%
+232
New +$2.37K
SNDL icon
3079
Sundial Growers
SNDL
$315M
$2.3K ﹤0.01%
859
CRD.A icon
3080
Crawford & Co Class A
CRD.A
$613M
$2.3K ﹤0.01%
+215
New +$2.26K
LUNG icon
3081
Pulmonx
LUNG
$92.8M
$2.3K ﹤0.01%
+1,420
New +$2.97K
LTBR icon
3082
Lightbridge
LTBR
$297M
$2.29K ﹤0.01%
+108
New +$1.63K
WOLF icon
3083
Wolfspeed
WOLF
$1.46B
$2.29K ﹤0.01%
84
-22
-21% -$52
PESI icon
3084
Perma-Fix Environmental Services
PESI
$370M
$2.28K ﹤0.01%
+226
New +$2.5K
QTRX icon
3085
Quanterix
QTRX
$179M
$2.27K ﹤0.01%
419
-374
-47% -$1.99K
ACVA icon
3086
ACV Auctions
ACVA
$1.31B
$2.26K ﹤0.01%
+228
New +$2.92K
RCEL icon
3087
Avita Medical
RCEL
$148M
$2.25K ﹤0.01%
+441
New +$2.3K
TRML
3088
DELISTED
Tourmaline Bio
TRML
$2.25K ﹤0.01%
47
-5
-10% -$139
AWF
3089
AllianceBernstein Global High Income Fund
AWF
$871M
$2.24K ﹤0.01%
+200
New +$2.23K
LOAR icon
3090
Loar Holdings
LOAR
$6.94B
$2.24K ﹤0.01%
+28
New +$2.1K
TCX icon
3091
Tucows
TCX
$158M
$2.23K ﹤0.01%
+120
New +$2.33K
ACU icon
3092
Acme United Corp
ACU
$211M
$2.22K ﹤0.01%
+54
New +$2.27K
STXS icon
3093
Stereotaxis
STXS
$136M
$2.2K ﹤0.01%
+708
New +$1.83K
SMMT icon
3094
Summit Therapeutics
SMMT
$10.8B
$2.19K ﹤0.01%
+106
New +$2.57K
MIST icon
3095
Milestone Pharmaceuticals
MIST
$144M
$2.15K ﹤0.01%
+1,077
New +$1.89K
TZOO icon
3096
Travelzoo
TZOO
$73.4M
$2.15K ﹤0.01%
+219
New +$2.35K
CPA icon
3097
Copa Holdings
CPA
$5.95B
$2.14K ﹤0.01%
+18
New +$2.06K
BVFL icon
3098
BV Financial
BVFL
$183M
$2.13K ﹤0.01%
+132
New +$2.14K
XRN
3099
Chiron Real Estate Inc
XRN
$464M
$2.12K ﹤0.01%
+63
New +$2.24K
BWIN
3100
Baldwin Insurance Group
BWIN
$2.83B
$2.12K ﹤0.01%
75
+62
+477% +$2.15K

Similar funds

Arax Advisory Partners's Q3 2025 Portfolio in Review

As of Q3 2025, Arax Advisory Partners held 4,400 positions worth $6.97B, up 220% from $2.18B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Arax Advisory Partners deployed $6.91B of net new capital in Q3 2025, opening 1,371 new positions and adding to 1,984 existing holdings. Its largest new stake was American Century Diversified Corporate Bond ETF: 3,224,236 shares worth $194M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 6.5% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Axon Enterprise, an estimated $58.1M trimmed.

  • Arax Advisory Partners's largest Q3 2025 buy was American Century Diversified Corporate Bond ETF: 3,224,236 shares worth $194M.
  • Arax Advisory Partners added most to iShares S&P 100 ETF in Q3 2025, an estimated $2.43B increase.
  • Arax Advisory Partners's biggest Q3 2025 reduction was Axon Enterprise, cutting an estimated $58.1M.
  • Arax Advisory Partners fully exited Vanguard Morningstar Growth ETF in Q3 2025, selling an estimated $91.2M.
  • Arax Advisory Partners's ten largest holdings make up 37% of its $6.97B portfolio in Q3 2025.
  • Arax Advisory Partners opened 1,371 new positions and closed 794 in Q3 2025.
  • Arax Advisory Partners's portfolio value rose 220% quarter-over-quarter to $6.97B.

Based on Arax Advisory Partners's 13F filing for Q3 2025, filed 14 Nov 2025.